- 全部删除
您的购物车当前为空
Bindarit 是单核细胞趋化蛋白MCP-1/CCL2,MCP-3/CCL7和MCP-2/CCL8的选择性抑制剂,具有抗炎作用。Bindarit 对 p65 和 p65/p50 诱导的 MCP-1 启动子激活具有特异性抑制作用,对其它测试的活化启动子没有影响。


为众多的药物研发团队赋能,
让新药发现更简单!
Bindarit 是单核细胞趋化蛋白MCP-1/CCL2,MCP-3/CCL7和MCP-2/CCL8的选择性抑制剂,具有抗炎作用。Bindarit 对 p65 和 p65/p50 诱导的 MCP-1 启动子激活具有特异性抑制作用,对其它测试的活化启动子没有影响。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 415 | In stock | |
| 2 mg | ¥ 597 | In stock | |
| 5 mg | ¥ 962 | In stock | |
| 10 mg | ¥ 1,450 | In stock | |
| 25 mg | ¥ 2,750 | In stock | |
| 50 mg | ¥ 4,130 | In stock | |
| 100 mg | ¥ 5,890 | In stock | |
| 500 mg | ¥ 11,900 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 686 | In stock |
Bindarit 相关产品
| 产品描述 | Bindarit is a selective inhibitor of monocyte chemoattractant proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8 with anti-inflammatory effects. Bindarit specifically inhibits p65- and p65/p50-induced MCP-1 promoter activation and has no effect on other tested activated promoters. |
| 靶点活性 | MCP-1:172 µM, CCL2:403 µM |
| 体外活性 | 方法:Bindarit (AF2838)(300μM,处理前1小时)的不同时间点(1,2,4,8,24小时)用LPS(1μg/ ml)刺激Raw 264.7细胞,研究bindarit发挥其抗炎作用的机制。 |
| 体内活性 | 方法:Bindarit (AF2838)(200μg/g)治疗OVX小鼠模型,验证CCL2和CCL7的表达。 |
| 别名 | 宾达利, AF2838 |
| 分子量 | 324.37 |
| 分子式 | C19H20N2O3 |
| CAS No. | 130641-38-2 |
| Smiles | CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O |
| 密度 | 1.18g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 25 mg/mL (77.07 mM), Sonication is recommended. DMSO: 45 mg/mL (138.73 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容